A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.